⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
APLS News
Apellis Pharmaceuticals, Inc. Common Stock
Vision Loss Takes an Emotional Toll. Hadley Is Addressing It.
businesswire.com
APLS
BrokerCentral Unlocks Personal Lines Panel with Applied Rating Hub Integration
globenewswire.com
APLS
Montis Biosciences Advances First-in-Class Dual-Action C1q Antibody with Strong Preclinical Proof-of-Concept in Neuroinflammatory Diseases
globenewswire.com
APLS
Montis Biosciences Advances First-in-Class Dual-Action C1q Antibody with Strong Preclinical Proof-of-Concept in Neuroinflammatory Diseases
globenewswire.com
APLS
Form 8-K
sec.gov
APLS
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
globenewswire.com
APLS
PFE
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
globenewswire.com
APLS
PFE
AGNC
Age Related Macular Degeneration Market to Reach $16.2 billion by 2033, Globally, by 2034 at 5% CAGR: Allied Market Research
prnewswire.com
REGN
NVS
ROG
BIIB
CHRS
SNY
APLS
BHC
IONS
Global Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036
globenewswire.com
ABBV
ALC
APLS
BHC
JNJ
PFE
REGN
TEVA
VTRS
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
APLS